Newsfeeds - Spark Newswire

1 minute read

Signet Jewelers Q4 EPS $5.01, Inline, Sales $2.80B Beat $2.77B Estimate

Today, 7:29 AM

Signet Jewelers (NYSE:SIG) reported quarterly earnings of $5.01 per share which met the analyst consensus estimate. This is a 20.72 percent increase over earnings of $4.15 per share from the same period last year. The

SIG

3 minute read

12 Consumer Discretionary Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 7:29 AM

ASO

3 minute read

50 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 7:29 AM

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share.

ACMR

1 minute read

News

Signet Jewelers Suspends Business Interaction With Russian-Owned Entities

By Bill Haddad

Today, 7:29 AM

-Reuters

SIG

4 minute read

Options

10 Consumer Discretionary Stocks With Whale Alerts In Today’s Session

By Benzinga Insights

Today, 7:29 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

AMZN

4 minute read

Options

10 Consumer Discretionary Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 7:29 AM

ABNB

1 minute read

Telsey Advisory Group Maintains Market Perform on Signet Jewelers, Lowers Price Target to $100

By Benzinga Newsdesk

Today, 7:29 AM

Telsey Advisory Group analyst Dana Telsey maintains Signet Jewelers (NYSE:SIG) with a Market Perform and lowers the price target from $110 to $100.

SIG

4 minute read

61 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:29 AM

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.

AFI

3 minute read

35 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 7:29 AM

Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.

AFI

2 minute read

4 Stocks Insiders Are Selling

By Lisa Levin

Today, 7:29 AM

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

GOOG